Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Realin Biotechnology is a Chinese biotechnology company specializing in the research, development, and production of natural plant extracts, cosmetic ingredients, and pharmaceutical intermediates. Headquartered in Xi'an, the company provides a wide range of high-purity active ingredients, including peptides, antioxidants, and herbal extracts used in the skincare, nutraceutical, and pharmaceutical industries. Their operations focus on advanced extraction technology and rigorous quality control to supply global markets with raw materials for health and beauty products. Key products in their portfolio include alpha-arbutin, resveratrol, and various cosmetic peptides like Palmitoyl Pentapeptide-4. The company operates primarily as a B2B supplier and manufacturer rather than a traditional drug discovery firm.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Realin Biotechnology.